DE1470125C3 - 4-Oxo-13,8-triazaspiro [4,5] decane - Google Patents
4-Oxo-13,8-triazaspiro [4,5] decaneInfo
- Publication number
- DE1470125C3 DE1470125C3 DE1470125A DEN0023357A DE1470125C3 DE 1470125 C3 DE1470125 C3 DE 1470125C3 DE 1470125 A DE1470125 A DE 1470125A DE N0023357 A DEN0023357 A DE N0023357A DE 1470125 C3 DE1470125 C3 DE 1470125C3
- Authority
- DE
- Germany
- Prior art keywords
- parts
- phenyl
- triazaspiro
- oxo
- decane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Wire Processing (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20462362A | 1962-06-22 | 1962-06-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE1470125A1 DE1470125A1 (de) | 1969-05-08 |
| DE1470125B2 DE1470125B2 (US06262066-20010717-C00035.png) | 1979-10-31 |
| DE1470125C3 true DE1470125C3 (de) | 1980-07-10 |
Family
ID=22758700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1470125A Expired DE1470125C3 (de) | 1962-06-22 | 1963-06-21 | 4-Oxo-13,8-triazaspiro [4,5] decane |
Country Status (9)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4080328A (en) * | 1971-07-13 | 1978-03-21 | Sumitomo Chemical Company, Limited | N-substituted heterocyclic derivatives and preparation thereof |
| BE792187A (fr) * | 1971-12-03 | 1973-03-30 | Sumitomo Chemical Co | Nouveaux derives d'alkylamines |
| US4066772A (en) * | 1975-07-21 | 1978-01-03 | Janssen Pharmaceutica N.V. | 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds |
| NZ181256A (en) * | 1975-07-21 | 1978-04-28 | Janssen Pharmaceutica Nv | 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives |
| DK139684A (da) * | 1983-04-11 | 1984-10-12 | Janssen Pharmaceutica Nv | N-aryl-alpha-amino-carboxamider |
| US5703088A (en) * | 1989-08-21 | 1997-12-30 | Beth Israel Deaconess Medical Center, Inc. | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| US5244902A (en) * | 1989-08-21 | 1993-09-14 | Beth Israel Hospital Association | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| US5574041A (en) * | 1990-03-16 | 1996-11-12 | Beth Israel Hospital Association | Use of spiperone derivatives as immunosuppressant agents |
| US5693645A (en) * | 1992-12-23 | 1997-12-02 | Beth Israel Deaconess Medical Center, Inc. | Use of spiperone or spiperone derivatives as immunosuppressant agents |
| DE19610397A1 (de) * | 1996-03-16 | 1997-09-18 | Krewel Meuselbach Gmbh | Gewinnung von Fluspirilen-Suspensionen |
| US6277991B1 (en) | 1998-05-18 | 2001-08-21 | Novo Nordisk A/S | 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| AU3809999A (en) * | 1998-05-18 | 1999-12-06 | Novo Nordisk A/S | Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| DE69923744T2 (de) * | 1998-10-23 | 2006-02-23 | Pfizer Inc. | 1,3,8-Triazaspiro[4,5] decanon Verbindungen als orl1-receptor Agonisten |
| US7459461B2 (en) | 2001-10-19 | 2008-12-02 | Ortho-Mcneil Pharmaceutical, Inc. | Phosphonic acid compounds as inhibitors of serine proteases |
| DE102005038141A1 (de) * | 2005-08-12 | 2007-02-15 | Grünenthal GmbH | Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate |
| NZ605431A (en) * | 2010-06-18 | 2015-06-26 | Altos Therapeutics Llc | D2 antagonists, methods of synthesis and methods of use |
| IT201800007580A1 (it) * | 2018-07-27 | 2020-01-27 | Maria Cecilia Hospital Spa | Composti 1,3,8-triazaspiro e loro uso come medicamenti |
-
0
- BE BE633914D patent/BE633914A/xx unknown
-
1963
- 1963-06-19 SE SE6834/63A patent/SE311019B/xx unknown
- 1963-06-21 NO NO149114A patent/NO117368B/no unknown
- 1963-06-21 CH CH776363A patent/CH462835A/de unknown
- 1963-06-21 GB GB24824/63A patent/GB1043141A/en not_active Expired
- 1963-06-21 DE DE1470125A patent/DE1470125C3/de not_active Expired
- 1963-06-21 FI FI631267A patent/FI46967C/fi active
- 1963-06-22 DK DK297763AA patent/DK119880B/da unknown
- 1963-06-22 FR FR1573808D patent/FR1573808A/fr not_active Expired
- 1963-09-20 FR FR948244A patent/FR3059M/fr active Active
- 1963-09-20 FR FR948242A patent/FR2987M/fr active Active
- 1963-09-20 FR FR948243A patent/FR2988M/fr active Active
- 1963-09-20 FR FR948240A patent/FR3043M/fr active Active
- 1963-09-20 FR FR948241A patent/FR2986M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB1043141A (en) | 1966-09-21 |
| NO117368B (US06262066-20010717-C00035.png) | 1969-08-04 |
| BE633914A (US06262066-20010717-C00035.png) | |
| DE1470125B2 (US06262066-20010717-C00035.png) | 1979-10-31 |
| FR1573808A (US06262066-20010717-C00035.png) | 1969-07-11 |
| SE311019B (US06262066-20010717-C00035.png) | 1969-05-27 |
| FI46967C (fi) | 1973-08-10 |
| DK119880B (da) | 1971-03-08 |
| DE1470125A1 (de) | 1969-05-08 |
| FR2986M (fr) | 1964-12-07 |
| FR2987M (fr) | 1964-12-07 |
| CH462835A (de) | 1968-09-30 |
| FR3043M (fr) | 1965-01-04 |
| FR3059M (fr) | 1965-01-11 |
| FR2988M (fr) | 1964-12-07 |
| FI46967B (US06262066-20010717-C00035.png) | 1973-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1470125C3 (de) | 4-Oxo-13,8-triazaspiro [4,5] decane | |
| DE1543714C3 (de) | Basisch substituierte Phthalanverbindungen und Verfahren zu ihrer Herstellung | |
| DE2336399A1 (de) | Substituierte benzamide, verfahren zu deren herstellung und diese verbindungen als wirkstoffe enthaltende pharmazeutische zubereitungen | |
| CH648553A5 (de) | Neue 3,4-dihydro-5h-2,3-benzodiazepin-derivate und verfahren zur herstellung derselben. | |
| CH635841A5 (de) | Spiroaminderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| DE60102473T2 (de) | Indolochinazolinone | |
| DE2363052A1 (de) | 3-phenyl-3-aminoalkyl-2,6-dioxo-tetraund -hexahydropyridine, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen | |
| CH646696A5 (de) | Dibenzazepine, ihre herstellung und verwendung. | |
| DE1135461B (de) | Verfahren zur Herstellung von basisch substituierten Phthalimidinen | |
| DE2504250A1 (de) | Tetrahydroisochinolin-derivate und verfahren zu ihrer herstellung | |
| DE2426149B2 (de) | 7-Fluor-substituierte Phenothiazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE1518452C3 (de) | 4 substituierte 2 Benzhydryl 2 butanol Derivate und Verfahren zu ihrer Herstellung | |
| DE2307708A1 (de) | Indolamine, verfahren zu ihrer herstellung und ihre verwendung | |
| DE1470123C3 (de) | 4-(2,6-Dioxo-3-phenyl-3-piperidyl>piperidine, deren pharmakologisch verträgliche Säureadditionssalze und Verfahren zu ihrer Herstellung | |
| DE2051962A1 (de) | Benzimidazo eckige Klammer auf l,2d eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu benzodiazepin 6 (5H) one und Verfahren zu deren Her stellung | |
| EP0018360A1 (de) | N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung. | |
| DE1795653A1 (de) | Verfahren zur herstellung von 2alkoxy-4.5-azimidobenzamiden | |
| DE1076691B (de) | Verfahren zur Herstellung von Phenthiazinderivaten | |
| DE2003744C2 (de) | In 3- und 4-Stellung disubstituierte 3-Amino-2-bicyclo[2,2,2]octan-2-ole, Verfahren zu deren Herstellung und dieselben enthaltende Arzneimittel | |
| DE1568104C3 (de) | Tricyclische N-alkylierte Derivate des Acetamide und Verfahren zu ihrer Herstellung | |
| CH644126A5 (de) | 4-phenyl-thieno-(2,3-c)-piperidine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
| CH644364A5 (de) | 4-(naphthalinyloxy)piperidin-derivate. | |
| DE1095283B (de) | Verfahren zur Herstellung von Phenthiazinderivaten | |
| US3228948A (en) | Phenyl granatane derivatives | |
| AT242137B (de) | Verfahren zur Herstellung von neuen Derivaten des 4-Aminobutin-(2, 3)-ols-1 und deren Salzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SH | Request for examination between 03.10.1968 and 22.04.1971 | ||
| C3 | Grant after two publication steps (3rd publication) |